Cumberland Pharmaceuticals (CPIX) Gross Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Gross Margin of 78.82% for Q1 2026, down 5.73% sequentially from 83.61% in Q4 2025, and down 901.0% YoY from 9.84% in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Gross Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Gross Margin for 17 years, with the latest figure at 78.82% in Q1 2026.
- Quarterly Gross Margin fell 901.0% year-over-year to 78.82% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 82.89% (down 144.0% YoY) and the FY2025 annual result came in at 85.02%, up 242.0% from the prior year.
- Gross Margin eased to 78.82% in Q1 2026 per CPIX's latest filing, from 83.61% in the prior quarter.
- Over five years, Gross Margin peaked at 88.08% in Q3 2025 and troughed at 70.95% in Q4 2022.
- A 5-year average of 82.41% and a median of 82.49% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2026: Gross Margin jumped 1269 bps in 2023, then plunged 901 bps in 2026.
- Over 5 years, Gross Margin stood at 70.95% in 2022, then climbed by 18 bps to 83.64% in 2023, then dropped by 3 bps to 81.06% in 2024, then grew by 3 bps to 83.61% in 2025, then fell by 6 bps to 78.82% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 78.82%, 83.61%, and 88.08% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.82% |
| Dec 31, 2025 | 83.61% |
| Sep 30, 2025 | 88.08% |
| Jun 30, 2025 | 81.44% |
| Mar 31, 2025 | 87.83% |
| Dec 31, 2024 | 81.06% |
| Sep 30, 2024 | 85.44% |
| Jun 30, 2024 | 82.63% |
| Mar 31, 2024 | 81.46% |
| Dec 31, 2023 | 83.64% |
| Sep 30, 2023 | 82.49% |
| Jun 30, 2023 | 86.03% |
| Mar 31, 2023 | 86.45% |
| Dec 31, 2022 | 70.95% |
| Sep 30, 2022 | 80.51% |
| Jun 30, 2022 | 80.27% |
| Mar 31, 2022 | 80.21% |
| Dec 31, 2021 | 60.03% |
| Sep 30, 2021 | 83.55% |
| Jun 30, 2021 | 80.78% |